Meridian Bioscience, Inc.
Period Ending Sep 30, 2013 Sep 30, 2012 Sep 30, 2011 Sep 30, 2010
Total Revenue 188,686 172,712 158,836 143,000
Cost of Revenue 67,642 63,664 60,425 54,304
Gross Profit 121,044 109,048 98,411 88,696
Operating Expenses
Research and Development 10,787 10,275 9,822 8,396
Sales, General and Admin. 52,943 49,477 48,556 39,162
Non-Recurring Items - - - -
Other - - - -
Operating Income 57,314 49,296 40,033 41,138
Income From Continuing Operations
Add'l Income/Expense Items 48 420 467 262
Earnings Before Interest and Tax 57,362 49,716 40,500 41,400
Interest Expense - - - -
Earnings Before Tax 57,362 49,716 40,500 41,400
Income Tax 19,330 16,345 13,669 14,753
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 38,032 33,371 26,831 26,647
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 38,032 33,371 26,831 26,647
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 38,032 33,371 26,831 26,647